Remarkably, RF failed to ameliorate colitis symptoms and improve survival in intestinal clock-deficient Bmal1IEC−/−xIL-10−/− mice, demonstrating the relevance of a functional intestinal clock in mediating the positive effect of RF; thus, RF might be a novel target for future IBD therapies. The gene discussed is CLOCK; the disease is colitis.